Ophthalmology Medical Billing Services

Ophthalmology billing has structural quirks no other specialty carries: a parallel code family (general ophthalmological service “eye codes”) alongside standard E/M with payer-by-payer preferences between them; a routing decision on nearly every encounter between the patient’s vision plan and medical insurance; cataract surgery globals with optometric co-management splits; and retina practices whose revenue is dominated by anti-VEGF injectable drugs.

Our ophthalmology billing manages each quirk deliberately: eye-code-versus-E/M selection by payer and encounter, refraction and vision-plan routing rules that prevent patient disputes, co-management splits billed correctly with the required transfer documentation, and injection drug billing reconciled at retina-practice volume.

Why Ophthalmology Billing Is Complex

The vision/medical split drives daily errors: routine exams belong to vision plans, medical eye problems to health insurance — and the encounter’s chief complaint determines routing, not what reimburses better. Cataract co-management requires documented transfer-of-care and correct modifier-based fee splits between surgeon and optometrist across the global. Anti-VEGF drugs price like oncology products: units, wastage, and per-eye authorization tracked injection by injection.

Common Service Categories We Bill

• Medical eye examinations and chronic disease management
• Cataract surgery with co-management arrangements
• Retina services and intravitreal injections
• Glaucoma monitoring and procedures
• Diagnostic imaging (OCT, visual fields, photography)

Common Denial Causes in Ophthalmology

• Vision/medical routing rejections and patient disputes
• Imaging frequency edits (OCT, fields) on monitoring patients
• Drug unit and authorization errors on anti-VEGF claims
• Global-period disputes across co-managed cataracts

Documentation Risks to Watch

• Chief complaint not supporting the plan billed (vision versus medical)
• Co-management transfer documentation absent or late
• Injection laterality and drug-lot records incomplete
• Diagnostic imaging frequency without refreshed indications

Coding Considerations

• Eye codes and E/M pay differently by payer with different documentation constructions — the profitable-and-defensible choice varies
• Bilateral injection billing rules and per-eye authorizations must align per encounter

Typical Payer Challenges

• Vision plan carve-outs adjacent to medical coverage on the same patient
• Step-therapy policies on anti-VEGF product selection